Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this pilot study is to investigate whether two major vasopressors (norepinephrine vs. phenylephrine) used for treatment of hypotension during breast reconstruction with free flap transfer surgery have different effects on blood flow of the flap vessel measured by transit time flowmetry. Since there are few prior studies that compared the effects of these two vasopressors on the blood flow of the flap, this study will be conducted in the form of a pilot study in order to establish the evidence for the future randomized controlled trial.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Norepinephrine | Active Comparator | Norepinephrine Bitartrate Hydrate : 4 mg/4 mL |
|
| Phenylephrine | Active Comparator | Phenylephrine hydrochloride : 10 mg/1 mL |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Norepinephrine | Drug |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| Graft mean blood flow measured using transit time flowmetry | Mean blood flow (in mL/min) of the graft vessel that was measured using transit time flowmetry | Intraoperative period |
| Pulsatility of graft vessel measured using transit time flowmetry | Pulsatility of graft vessel, which is presented as pulsatility index in unitless, that was measured using transit time flowmetry | Intraoperative period |
| Diastolic filling of the graft vessel measured using transit time flowmetry | Diastolic filling (in percentage) of the graft vessel that was measured using transit time flowmetry | Intraoperative period |
| Measure | Description | Time Frame |
|---|---|---|
| Graft failure rate in patients received each vasopressor during surgery | The rate of graft failure in patients received each vasopressor during surgery | Within seven days after surgery |
| Capillary filling time in patients received each vasopressor during surgery |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Seoul National University Hospital | Seoul | 03080 | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009638 | Norepinephrine |
| D010656 | Phenylephrine |
| ID | Term |
|---|---|
| D004983 | Ethanolamines |
| D000605 | Amino Alcohols |
| D000438 | Alcohols |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Phenylephrine | Drug |
|
|
Capillary filling time, which was measured by time to refill the capillary after compression, to evaluate the viability of the flap in patients received each vasopressor during surgery |
| Within seven days after surgery |
| Skin necrosis rate in patients received each vasopressor during surgery | The rate of skin necrosis, which is evaluated by any changes in skin color by description of the color of the skin by clinicians, to evaluate the viability of the graft in patients received each vasopressor during surgery | Within seven days after surgery |
| Rate of vascular thrombosis in patients received each vasopressor during surgery | The rate of arterial or venous complication by measure of skin color change or decrease in doppler flow or capillary refill to evaluate the viability of the graft in patients received each vasopressor during surgery | Within seven days after surgery |
| Rate of wound infection or any wound problem in patients received each vasopressor during surgery | The rate of any wound complication including infection to evaluate wound complication after surgery in patients each vasopressor during surgery | Within seven days after surgery |
| Amount of transfusion in patients received each vasopressor during surgery | Amount of transfusion to evaluate clinical outcomes in patients received each vasopressor during surgery | Within seven days after surgery |
| Total amount of remifentanil infused during surgery in patients received each vasopressor | The total amount of remifentanil infused during surgery to evaluate clinical outcomes and perioperative variables in patients received each vasopressor during surgery | intraoperative period |
| Total amount of inotropic agents or vasopressor during surgery in patients received each vasopressor | The total amount of inotropic agents or vasopressor during surgery to evaluate clinical outcomes and perioperative variables in patients received each vasopressor during surgery | intraoperative period |
| Stroke volume during surgery in patients received each vasopressor | Stroke volume (in mL) measured by FlowTrac parameters to evaluate the intraoperative hemodynamics in patients received each vasopressor | intraoperative period |
| Cardiac index during surgery in patients received each vasopressor | Cardiac index (in L/min/m^2) measured by FlowTrac parameters to evaluate the intraoperative hemodynamics in patients received each vasopressor | intraoperative period |
| Stroke volume variation during surgery in patients received each vasopressor | Stroke volume variation (in percentage) measured by FlowTrac parameters to evaluate the intraoperative hemodynamics in patients received each vasopressor | intraoperative period |
| Serum lactate levels in patients received each vasopressor | Serum lactate levels (in mmol/L) to evaluate the postoperative variables and clinical outcomes in patients received each vasopressor during surgery | Within seven days after surgery |
| Wound exploration rate in patients received each vasopressor during surgery | The rate of wound exploration as a measure of postoperative complication and graft failure to evaluate the flap outcome in patients received each vasopressor during surgery | Until discharge |
| Reoperation rate in patients received each vasopressor during surgery | The rate of reoperation as a measure of postoperative complication and graft failure to evaluate the flap outcome in patients received each vasopressor during surgery | Until discharge |
| D000588 |
| Amines |
| D015306 | Biogenic Monoamines |
| D001679 | Biogenic Amines |
| D002395 | Catecholamines |
| D002396 | Catechols |
| D010636 | Phenols |
| D001555 | Benzene Derivatives |
| D006841 | Hydrocarbons, Aromatic |
| D006844 | Hydrocarbons, Cyclic |
| D006838 | Hydrocarbons |